GLASAMYR Trademark

Trademark Overview

On Friday, January 25, 2019, a trademark application was filed for GLASAMYR with the United States Patent and Trademark Office. The USPTO has given the GLASAMYR trademark a serial number of 88276740. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 22, 2022. This trademark is owned by Dr, Reddy's Laboratories Inc.. The GLASAMYR trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation for use in human medicine for the treatment of multiple sclerosis
glasamyr

General Information

Serial Number88276740
Word MarkGLASAMYR
Filing DateFriday, January 25, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 22, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2019

Trademark Statements

Goods and Servicespharmaceutical preparation for use in human medicine for the treatment of multiple sclerosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, February 17, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDr, Reddy's Laboratories Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540
Party NameDr, Reddy's Laboratories Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08540

Trademark Events

Event DateEvent Description
Monday, August 22, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 22, 2022ABANDONMENT - NO USE STATEMENT FILED
Saturday, January 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 21, 2022SOU EXTENSION 5 GRANTED
Thursday, January 13, 2022SOU EXTENSION 5 FILED
Friday, January 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 13, 2022TEAS EXTENSION RECEIVED
Saturday, July 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 15, 2021SOU EXTENSION 4 GRANTED
Thursday, July 15, 2021SOU EXTENSION 4 FILED
Thursday, July 15, 2021TEAS EXTENSION RECEIVED
Thursday, January 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 19, 2021SOU EXTENSION 3 GRANTED
Tuesday, January 19, 2021SOU EXTENSION 3 FILED
Tuesday, January 19, 2021TEAS EXTENSION RECEIVED
Wednesday, July 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 13, 2020SOU EXTENSION 2 GRANTED
Monday, July 13, 2020SOU EXTENSION 2 FILED
Monday, July 13, 2020TEAS EXTENSION RECEIVED
Wednesday, January 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 13, 2020SOU EXTENSION 1 GRANTED
Monday, January 13, 2020SOU EXTENSION 1 FILED
Monday, January 13, 2020TEAS EXTENSION RECEIVED
Friday, January 10, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, January 10, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, July 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 21, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 21, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 1, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 8, 2019ASSIGNED TO EXAMINER
Sunday, February 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 29, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

glasamyr multiple sclerosis treatment medicine preparation human pharmaceutical